Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome
Crossref DOI link: https://doi.org/10.1007/s12325-021-01907-3
Published Online: 2021-12-13
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Dandan
Sun, Yang
Ye, Xiaoran
Li, Lanting
Chen, Yundai
Wang, Daowen
Funding for this research was provided by:
Sanofi
Text and Data Mining valid from 2021-12-13
Version of Record valid from 2021-12-13
Article History
Received: 16 April 2021
Accepted: 26 August 2021
First Online: 13 December 2021